These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 38527521

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Loss of GIPR in LEPR cells impairs glucose control by GIP and GIP:GLP-1 co-agonism without affecting body weight and food intake in mice.
    Akindehin S, Liskiewicz A, Liskiewicz D, Bernecker M, Garcia-Caceres C, Drucker DJ, Finan B, Grandl G, Gutgesell R, Hofmann SM, Khalil A, Liu X, Cota P, Bakhti M, Czarnecki O, Bastidas-Ponce A, Lickert H, Kang L, Maity G, Novikoff A, Parlee S, Pathak E, Schriever SC, Sterr M, Ussar S, Zhang Q, DiMarchi R, Tschöp MH, Pfluger PT, Douros JD, Müller TD.
    Mol Metab; 2024 May; 83():101915. PubMed ID: 38492844
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Optimized GIP analogs promote body weight lowering in mice through GIPR agonism not antagonism.
    Mroz PA, Finan B, Gelfanov V, Yang B, Tschöp MH, DiMarchi RD, Perez-Tilve D.
    Mol Metab; 2019 Feb; 20():51-62. PubMed ID: 30578168
    [Abstract] [Full Text] [Related]

  • 5. Targeting the GIPR for obesity: To agonize or antagonize? Potential mechanisms.
    Campbell JE.
    Mol Metab; 2021 Apr; 46():101139. PubMed ID: 33290902
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Incretin-mediated control of cardiac energy metabolism.
    Chan JSF, Shafaati T, Ussher JR.
    J Endocrinol; 2024 Oct 01; 263(1):. PubMed ID: 39013412
    [Abstract] [Full Text] [Related]

  • 8. Human epicardial adipose tissue expresses glucose-dependent insulinotropic polypeptide, glucagon, and glucagon-like peptide-1 receptors as potential targets of pleiotropic therapies.
    Malavazos AE, Iacobellis G, Dozio E, Basilico S, Di Vincenzo A, Dubini C, Menicanti L, Vianello E, Meregalli C, Ruocco C, Ragni M, Secchi F, Spagnolo P, Castelvecchio S, Morricone L, Buscemi S, Giordano A, Goldberger JJ, Carruba M, Cinti S, Corsi Romanelli MM, Nisoli E.
    Eur J Prev Cardiol; 2023 Jun 01; 30(8):680-693. PubMed ID: 36799940
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. GIPR Function in the Central Nervous System: Implications and Novel Perspectives for GIP-Based Therapies in Treating Metabolic Disorders.
    Samms RJ, Sloop KW, Gribble FM, Reimann F, Adriaenssens AE.
    Diabetes; 2021 Sep 01; 70(9):1938-1944. PubMed ID: 34176786
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A Dual GLP-1/GIP Receptor Agonist Does Not Antagonize Glucagon at Its Receptor but May Act as a Biased Agonist at the GLP-1 Receptor.
    Al-Zamel N, Al-Sabah S, Luqmani Y, Adi L, Chacko S, Schneider TD, Krasel C.
    Int J Mol Sci; 2019 Jul 19; 20(14):. PubMed ID: 31330984
    [Abstract] [Full Text] [Related]

  • 15. Discovery of a potent GIPR peptide antagonist that is effective in rodent and human systems.
    Yang B, Gelfanov VM, El K, Chen A, Rohlfs R, DuBois B, Kruse Hansen AM, Perez-Tilve D, Knerr PJ, D'Alessio D, Campbell JE, Douros JD, Finan B.
    Mol Metab; 2022 Dec 19; 66():101638. PubMed ID: 36400403
    [Abstract] [Full Text] [Related]

  • 16. Pharmacological Advances in Incretin-Based Polyagonism: What We Know and What We Don't.
    Novikoff A, Müller TD.
    Physiology (Bethesda); 2024 May 01; 39(3):142-156. PubMed ID: 38353610
    [Abstract] [Full Text] [Related]

  • 17. Differential effects of glucose-dependent insulinotropic polypeptide receptor/glucagon-like peptide-1 receptor heteromerization on cell signaling when expressed in HEK-293 cells.
    Al-Zaid B, Chacko S, Ezeamuzie CI, Bünemann M, Krasel C, Karimian T, Lanzerstorfer P, Al-Sabah S.
    Pharmacol Res Perspect; 2022 Oct 01; 10(5):e01013. PubMed ID: 36177761
    [Abstract] [Full Text] [Related]

  • 18. Glucose-dependent insulinotropic polypeptide regulates body weight and food intake via GABAergic neurons in mice.
    Liskiewicz A, Khalil A, Liskiewicz D, Novikoff A, Grandl G, Maity-Kumar G, Gutgesell RM, Bakhti M, Bastidas-Ponce A, Czarnecki O, Makris K, Lickert H, Feuchtinger A, Tost M, Coupland C, Ständer L, Akindehin S, Prakash S, Abrar F, Castelino RL, He Y, Knerr PJ, Yang B, Hogendorf WFJ, Zhang S, Hofmann SM, Finan B, DiMarchi RD, Tschöp MH, Douros JD, Müller TD.
    Nat Metab; 2023 Dec 01; 5(12):2075-2085. PubMed ID: 37946085
    [Abstract] [Full Text] [Related]

  • 19. Immunomodulation and inflammation: Role of GLP-1R and GIPR expressing cells within the gut.
    Morrow NM, Morissette A, Mulvihill EE.
    Peptides; 2024 Jun 01; 176():171200. PubMed ID: 38555054
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.